InvestorsHub Logo
Followers 4
Posts 211
Boards Moderated 0
Alias Born 02/23/2024

Re: None

Tuesday, 05/14/2024 8:06:12 AM

Tuesday, May 14, 2024 8:06:12 AM

Post# of 6874
Email this morning: Top line results expected to be imminent for company’s phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea

IMMINENT (not forthcoming anymore), what other hint do you want?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News